Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Val R Adams

Showing results (1-10 of 32) with videos related to

Pageof 4
Sort By:
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 28, 2006
Evolving role of antineoplastic agents in colorectal cancerVal R Adams
Journal of the Advanced Practitioner in Oncology|June 4, 2021
Sticky Issues: What APs Need to Know About Anticoagulants and Patients With CancerVal R Adams
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 2, 2010
An important recent development in cancer research has been the identification of new genetic and molecular tumor profiling techniques. IntroductionVal R Adams, Sheetal Sheth
Clinical Therapeutics|September 11, 2007
Sunitinib malate for the treatment of metastatic renal cell carcinoma and gastrointestinal stromal tumorsVal R Adams, Markos Leggas
Healthcare (Basel, Switzerland)|July 16, 2016
Incidence and Risk Factors of Thromboembolism with Multiple Myeloma in the Presence of Death as a Competing Risk: An Empirical Comparison of Statistical MethodologiesJoshua D Brown, Val R Adams
Pharmacotherapy|January 30, 2016
PD-1 Pathway Inhibitors: Immuno-Oncology Agents for Restoring Antitumor Immune ResponsesPatrick J Medina, Val R Adams
Oncotargets and Therapy|April 27, 2017
Targeting the PD-1 pathway in pediatric solid tumors and brain tumorsLars M Wagner, Val R Adams
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|September 25, 2002
Pegfilgrastim: a new therapy to prevent neutropenic feverAimee K Bence, Val R Adams
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 2, 2010
Histological and genetic markers for non-small-cell lung cancer: customizing treatment based on individual tumor biologyVal R Adams, R Donald Harvey
Journal of Health Economics and Outcomes Research|August 20, 2021
Competing Risks Analysis of Cancer-associated Recurrent Thrombosis, Major Bleeds, and Death in a Geriatric CohortJoshua D Brown, Kelley L Ratermann, Kelley L Ratermann, et al.
Pageof 4

Showing results (1-10 of 32) with videos related to

Sort By:
Pageof 4
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|April 28, 2006
Evolving role of antineoplastic agents in colorectal cancerVal R Adams
Journal of the Advanced Practitioner in Oncology|June 4, 2021
Sticky Issues: What APs Need to Know About Anticoagulants and Patients With CancerVal R Adams
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 2, 2010
An important recent development in cancer research has been the identification of new genetic and molecular tumor profiling techniques. IntroductionVal R Adams, Sheetal Sheth
Clinical Therapeutics|September 11, 2007
Sunitinib malate for the treatment of metastatic renal cell carcinoma and gastrointestinal stromal tumorsVal R Adams, Markos Leggas
Healthcare (Basel, Switzerland)|July 16, 2016
Incidence and Risk Factors of Thromboembolism with Multiple Myeloma in the Presence of Death as a Competing Risk: An Empirical Comparison of Statistical MethodologiesJoshua D Brown, Val R Adams
Pharmacotherapy|January 30, 2016
PD-1 Pathway Inhibitors: Immuno-Oncology Agents for Restoring Antitumor Immune ResponsesPatrick J Medina, Val R Adams
Oncotargets and Therapy|April 27, 2017
Targeting the PD-1 pathway in pediatric solid tumors and brain tumorsLars M Wagner, Val R Adams
Journal of the American Pharmaceutical Association (Washington, D.C. : 1996)|September 25, 2002
Pegfilgrastim: a new therapy to prevent neutropenic feverAimee K Bence, Val R Adams
American Journal of Health-System Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists|January 2, 2010
Histological and genetic markers for non-small-cell lung cancer: customizing treatment based on individual tumor biologyVal R Adams, R Donald Harvey
Journal of Health Economics and Outcomes Research|August 20, 2021
Competing Risks Analysis of Cancer-associated Recurrent Thrombosis, Major Bleeds, and Death in a Geriatric CohortJoshua D Brown, Kelley L Ratermann, Kelley L Ratermann, et al.
Pageof 4